WO2008016958B1 - Reproductive cell media compositions and methods for improving fertility - Google Patents
Reproductive cell media compositions and methods for improving fertilityInfo
- Publication number
- WO2008016958B1 WO2008016958B1 PCT/US2007/074935 US2007074935W WO2008016958B1 WO 2008016958 B1 WO2008016958 B1 WO 2008016958B1 US 2007074935 W US2007074935 W US 2007074935W WO 2008016958 B1 WO2008016958 B1 WO 2008016958B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- reproductive
- growth factor
- reproductive cell
- colostrum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/061—Sperm cells, spermatogonia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Disclosed are compositions for reproductive cells which comprise a suitable reproductive cell media and a milk- or colostrum-derived product. The milk- or colostrum-derived product may comprise a growth factor, such as a transforming growth factor or insulin-like growth factor, or α-lactalbumin. The compositions may be optionally substantially free of bovine serum derived products. Methods for improving fertility in animals using compositions of the invention are also disclosed.
Claims
1. A composition comprising a reproductive cell medium, a milk- or colostrum- derived growth factor, and α-lactalbumin.
2. The composition of claim 1 , wherein the growth factor comprises IGF-1.
3. The composition of claim 1 , wherein the growth factor comprises TGF-β2.
4. The composition of claim 1, comprising milk- or colostrum-derived IGF-1 and milk- or colostrum-derived TGF-β2.
5. The composition of claim 4, wherein the ratio of IGF-1 to TGF-β2 is from about 5:1 to about 2:1.
6. Canceled
7. The composition of any of claims 1 to 5, wherein the reproductive cell medium is a sperm cell medium.
8. The composition of any of claims 1 to 5 and 7, wherein the reproductive cell medium is reproductive mammalian cell medium.
9. The composition of any of claims 1 to 5 and 7-8, wherein the composition is substantially free of bovine serum-derived products.
10. The composition of any of claims 1 to 5 and 7-9, further comprising a reproductive cell.
11. The composition of claim 10, wherein the reproductive cell is a sperm cell or oocyte.
12. The composition of any of claims 10 to 11, wherein the reproductive cell Is a mammalian cell.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82104406P | 2006-08-01 | 2006-08-01 | |
| US60/821,044 | 2006-08-01 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| WO2008016958A2 WO2008016958A2 (en) | 2008-02-07 |
| WO2008016958A3 WO2008016958A3 (en) | 2008-03-20 |
| WO2008016958B1 true WO2008016958B1 (en) | 2008-05-08 |
Family
ID=38997829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2007/074935 Ceased WO2008016958A2 (en) | 2006-08-01 | 2007-08-01 | Reproductive cell media compositions and methods for improving fertility |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008016958A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20100300A1 (en) * | 2010-06-03 | 2011-12-04 | Lo Li Pharma Srl | FORMULATION OF COMPOUND FOR THE TREATMENT OF SEMINAL MALE LIQUID INTENDED FOR MEDICALLY ASSISTED REPRODUCTION TECHNIQUES |
| US10279013B2 (en) | 2013-12-19 | 2019-05-07 | Puretein Bioscience Llc | Methods for treating an animal |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4511558A (en) * | 1983-05-16 | 1985-04-16 | University Patents, Inc. | Alpha-lactalbumin contraceptive |
| US6849394B2 (en) * | 2002-02-21 | 2005-02-01 | Minitube Of America | Compositions comprising reproductive cell media and methods for using such compositions |
-
2007
- 2007-08-01 WO PCT/US2007/074935 patent/WO2008016958A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008016958A2 (en) | 2008-02-07 |
| WO2008016958A3 (en) | 2008-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wrenzycki et al. | Alterations in the relative abundance of gene transcripts in preimplantation bovine embryos cultured in medium supplemented with either serum or PVA | |
| Baker et al. | Using deubiquitylating enzymes as research tools | |
| WO2010102085A4 (en) | Stabilized reverse transcriptase fusion proteins | |
| WO2003072707B1 (en) | Compositions comprising reproductive cell media and methods for using such compositions | |
| CA2601455C (en) | Dimeric and trimeric nucleic acid dyes, and associated systems and methods | |
| BRPI0516572A (en) | methods and compositions for improving the production of recombinant proteins | |
| MY185872A (en) | Cell culture improvements | |
| EP2426221A3 (en) | Recombinase polymerase amplification | |
| CA3049825C (en) | Cell-free protein synthesis system | |
| CA2474734A1 (en) | Thermostable taq polymerase fragment | |
| WO2008027384A8 (en) | Methods and compositions for transposon-mediated transgenesis | |
| WO2008016958B1 (en) | Reproductive cell media compositions and methods for improving fertility | |
| Guo et al. | Obox4 secures zygotic genome activation upon loss of Dux | |
| WO2020053683A1 (en) | Process for production of soluble recombinant peptides | |
| WO2006039622A3 (en) | Feeding buffers, systems, and methods for in vitro synthesis of biomolecules | |
| WO2008126783A1 (en) | Method for producing dipeptide | |
| CA3160450A1 (en) | Modular, cell-free protein expression vectors to accelerate biological design in cells | |
| WO2007015691A3 (en) | Methods and compositions for increasing longevity and protein yield from a cell culture | |
| Lee et al. | Identification of signals required for import of the soybean FAd subunit of ATP synthase into mitochondria | |
| CA3215576A1 (en) | Anti-izumo1 immunoglobulins and methods of use thereof | |
| WO2020135623A1 (en) | Method for changing in-vitro protein synthesis capability by edc3 gene knockout and application thereof | |
| EP3564367A1 (en) | Method of selecting cells | |
| 류다영 | Enhancing Solubility and Purification Efficiency of Vitronectin in Escherichia coli and Application in Human Pluripotent Stem Cell Culture | |
| WO2005023980A3 (en) | Use of complement protein c3 and its derivatives in enhancing mammalian embryo development | |
| Sood et al. | Paternal sex chromosome effect on development of buffalo (Bubalus Bubaus) embryos fertilized and cultured In vitro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07813633 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| NENP | Non-entry into the national phase in: |
Ref country code: RU |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07813633 Country of ref document: EP Kind code of ref document: A2 |